Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirong Kang

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Tumori|September 9, 2017
Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cellsYing Ma, Shirong Kang, Xu Wu, et al.
Frontiers in Oncology|November 1, 2023
Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancerMin Gao, Yongwen Li, Peijun Cao, et al.
International Journal of Clinical and Experimental Pathology|June 23, 2015
Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapyBateer Han, Zhanlin Guo, Ying Ma, et al.
International Journal of Clinical and Experimental Pathology|June 23, 2015
Assoication of XRCC1 gene polymorphisms with risk of non-small cell lung cancerShirong Kang, Ying Ma, Caixia Liu, et al.
Environmental Research|June 8, 2023
Functionalized 2D defect g-CShirong Kang, Xiaojie Liu, Zixian Wang, et al.
Medical Oncology (Northwood, London, England)|January 30, 2015
The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomasJiafeng Qi, Huiling Li, Nanbo Liu, et al.
Oncotargets and Therapy|July 10, 2023
Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han PopulationMin Gao, Yongwen Li, Hua Huang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Tumori|September 9, 2017
Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cellsYing Ma, Shirong Kang, Xu Wu, et al.
Frontiers in Oncology|November 1, 2023
Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancerMin Gao, Yongwen Li, Peijun Cao, et al.
International Journal of Clinical and Experimental Pathology|June 23, 2015
Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapyBateer Han, Zhanlin Guo, Ying Ma, et al.
International Journal of Clinical and Experimental Pathology|June 23, 2015
Assoication of XRCC1 gene polymorphisms with risk of non-small cell lung cancerShirong Kang, Ying Ma, Caixia Liu, et al.
Environmental Research|June 8, 2023
Functionalized 2D defect g-CShirong Kang, Xiaojie Liu, Zixian Wang, et al.
Medical Oncology (Northwood, London, England)|January 30, 2015
The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomasJiafeng Qi, Huiling Li, Nanbo Liu, et al.
Oncotargets and Therapy|July 10, 2023
Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han PopulationMin Gao, Yongwen Li, Hua Huang, et al.
Pageof 1